September 01, 2023
NOVARTIS PHARMACEUTICALS CORPORATION v. BECERRA et al
Case Number:
3:23-cv-14221
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Buttaci Leardi
- Carella Byrne
- Flitter Milz
- Green Savits
- Latham & Watkins
- Motley Rice
- Weissman & Mintz
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Center for American Progress
- Public Citizen Inc.
- UnidosUS
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 21, 2024
Novartis Loses Challenge To Medicare Drug Price Talks
A New Jersey federal judge on Friday tossed Novartis Pharmaceuticals' challenge to a Medicare drug price negotiation program, ruling the company is not required to participate, and that participating in the program does not violate its First Amendment rights.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login